Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Abbott LaboratoriesABT |
-$412M |
 |
CG OncologyCGON |
-$434M |
 |
TalkspaceTALK |
$12M |
 |
Inspire Veterinary PartnersIVP |
-$1,000,000 |
 |
Tempus AITEM |
-$122B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Livingston Mark S. | Dec 11, 2025 | Sell | 459 | $25.5 | $12,000 |
| Swartz Allison | Dec 4, 2025 | Sell | 530 | $24.59 | $13,000 |
| Livingston Mark S. | Dec 2, 2025 | Sell | 213 | $25.5 | $5,400 |
| Swartz Allison | Nov 28, 2025 | Sell | 2,398 | $26.87 | $64,000 |
| Livingston Mark S. | Nov 17, 2025 | Sell | 21,303 | $25.5 | $540,000 |
| Anevski Peter | Nov 13, 2025 | Buy | 79,500 | $24.288 | $1.9M |
| Swartz Allison | Sep 4, 2025 | Sell | 599 | $23.53 | $14,000 |
| Swartz Allison | Aug 28, 2025 | Sell | 2,398 | $22.96 | $55,000 |
| GORDON KEVIN K | Aug 11, 2025 | Sell | 2,500 | $22.035 | $55,000 |
| Scott Cheryl | Jun 11, 2025 | Sell | 2,675 | $22.07 | $59,000 |
| Schlanger David J | Dec 26, 2024 | Buy | 150,000 | $14.6822 | $2.2M |
| Anevski Peter | Dec 23, 2024 | Buy | 209,500 | $14.4825 | $3M |
| Payson Norman | Nov 23, 2024 | Sell | 200 | $56.29 | $11,000 |
| Sturmer Michael E | Jul 16, 2024 | Sell | 9,030 | $30 | $270,000 |
| Scott Cheryl | Jun 28, 2024 | Sell | 1,462 | $28.39 | $42,000 |
| Sturmer Michael E | May 1, 2024 | Sell | 4,515 | $31.95 | $140,000 |
| Schlanger David J | Apr 1, 2024 | Sell | 1,000 | $37.5225 | $38,000 |
| Sturmer Michael E | Apr 1, 2024 | Sell | 4,515 | $37.6 | $170,000 |
| Sturmer Michael E | Apr 1, 2024 | Sell | 1,880 | $37.6 | $71,000 |
| Livingston Mark S. | Apr 1, 2024 | Sell | 9,036 | $37.6194 | $340,000 |
| Livingston Mark S. | Apr 1, 2024 | Sell | 2,129 | $37.6 | $80,000 |
| Schlanger David J | Mar 27, 2024 | Sell | 71,272 | $37.8026 | $2.7M |
| Schlanger David J | Mar 26, 2024 | Sell | 305 | $37.5034 | $11,000 |
| Schlanger David J | Mar 25, 2024 | Sell | 2,597 | $37.6504 | $98,000 |
| Schlanger David J | Mar 21, 2024 | Sell | 5,826 | $37.7406 | $220,000 |
| Livingston Mark S. | Mar 1, 2024 | Sell | 8,222 | $36.671 | $300,000 |
| Livingston Mark S. | Mar 1, 2024 | Sell | 1,872 | $36.63 | $69,000 |
| Livingston Mark S. | Mar 1, 2024 | Sell | 1,388 | $36.667 | $51,000 |
| Livingston Mark S. | Mar 1, 2024 | Sell | 1,128 | $36.35 | $41,000 |
| Sturmer Michael E | Mar 1, 2024 | Sell | 11,009 | $36.63 | $400,000 |
| Sturmer Michael E | Feb 6, 2024 | Sell | 2,260 | $40 | $90,000 |
| Schlanger David J | Feb 5, 2024 | Sell | 14,138 | $38.3464 | $540,000 |
| Schlanger David J | Feb 5, 2024 | Sell | 5,862 | $38.8581 | $230,000 |
| Schlanger David J | Feb 2, 2024 | Sell | 16,741 | $38.66 | $650,000 |
| Schlanger David J | Feb 2, 2024 | Sell | 13,259 | $39.24 | $520,000 |
| Livingston Mark S. | Feb 1, 2024 | Sell | 9,651 | $37.83 | $370,000 |
| Livingston Mark S. | Feb 1, 2024 | Sell | 3,000 | $37.89 | $110,000 |
| Sturmer Michael E | Feb 1, 2024 | Sell | 4,515 | $37.89 | $170,000 |
| Sturmer Michael E | Feb 1, 2024 | Sell | 1,880 | $37.89 | $71,000 |
| Schlanger David J | Feb 1, 2024 | Sell | 17,742 | $38.01 | $670,000 |
| Schlanger David J | Feb 1, 2024 | Sell | 12,258 | $38.69 | $470,000 |
FAQ - Insider Transactions
The most recent insider transaction for Progyny was conducted by Livingston Mark S., who sold 459 shares on December 11, 2025 at a price of $25.50 per share.
Anevski Peter has bought the most PGNY stock in the last 2 years, with a total value of $5M.
Schlanger David J has sold the most PGNY stock in the last 2 years, with a total value of $6.1M.
The total value of insider transactions for Progyny in the last 2 years is negative, amounting to -$2.6M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Progyny have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
